Melexis NV
MELE: XBRU (BEL)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| @^? | LOCK|d>%Y | LOCK|lKd^KGj@ |
Melexis Earnings: Order Visibility Still Low, but Management's Demand Comments More Constructive
Melexis' second-quarter sales of EUR 217.1 million were ahead of guidance, and management's EUR 220 million-EUR 225 million guidance for the third quarter is ahead of consensus.
